BIOREM Inc.
BRM.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -60.02% | -11.34% | -11.89% | 39.06% | 705.12% |
| Total Depreciation and Amortization | -5.29% | 40.50% | 38.76% | 21.93% | 111.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.32% | -44.87% | -45.13% | -7.06% | 13,919.79% |
| Change in Net Operating Assets | 79.64% | 287.40% | 135.13% | 87.09% | -190.82% |
| Cash from Operations | -56.28% | -7.80% | 8.14% | 665.61% | 72.18% |
| Capital Expenditure | -34.64% | 31.94% | 88.96% | 33.18% | 66.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -34.64% | 31.94% | 88.96% | 33.18% | 66.41% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.32% | 50.32% | 51.34% | 47.86% | 53.51% |
| Issuance of Common Stock | -- | -- | -- | 127.39% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.86% | 69.95% | 67.41% | 57.43% | 51.85% |
| Foreign Exchange rate Adjustments | -225.38% | 66.37% | 781.54% | 310.11% | 119.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -81.15% | 51.80% | 191.58% | 300.18% | 508.27% |